Biochip-based detection of KRAS mutation in non-small cell lung cancer.

about

Non-small cell lung cancer: the era of targeted therapy.

P2860

Q37645231-92C2623A-AB07-4EC0-A334-4637A6E8C4F9

P2860

Biochip-based detection of KRAS mutation in non-small cell lung cancer.

Item

http://www.wikidata.org/entity/Q35669440

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Biochip-based detection of KRAS mutation in non-small cell lung cancer.

@ast

Biochip-based detection of KRAS mutation in non-small cell lung cancer.

@en

type

Item

label

Biochip-based detection of KRAS mutation in non-small cell lung cancer.

@ast

Biochip-based detection of KRAS mutation in non-small cell lung cancer.

@en

prefLabel

Biochip-based detection of KRAS mutation in non-small cell lung cancer.

@ast

Biochip-based detection of KRAS mutation in non-small cell lung cancer.

@en

P1476

Biochip-based detection of KRAS mutation in non-small cell lung cancer.

@en

P2093

Adelheid End

http://www.w3.org/2001/XMLSchema#string

Barbara Ziegler

http://www.w3.org/2001/XMLSchema#string

Gerhild Fabjani

http://www.w3.org/2001/XMLSchema#string

Gernot Kriegshäuser

http://www.w3.org/2001/XMLSchema#string

P2860

KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

Genome wide SNP comparative analysis between EGFR and KRAS mutated NSCLC and characterization of two models of oncogenic cooperation in non-small cell lung carcinoma

Diagnostic biochip array for fast and sensitive detection of K-ras mutations in stool.

Topographic analysis of K- ras mutations in histologically normal lung tissues and tumours of lung cancer patients.

High resolution melting analysis for the rapid and sensitive detection of mutations in clinical samples: KRAS codon 12 and 13 mutations in non-small cell lung cancer.

High resolution melting analysis for rapid and sensitive EGFR and KRAS mutation detection in formalin fixed paraffin embedded biopsies.

KRAS mutation analysis in ovarian samples using a high sensitivity biochip assay.

Targeted KRAS mutation assessment on patient tumor histologic material in real time diagnostics.

Rapid KRAS, EGFR, BRAF and PIK3CA mutation analysis of fine needle aspirates from non-small-cell lung cancer using allele-specific qPCR.

P304

8530-8538

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/IJMS12128530

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Robert Zeillinger

Sabine Zöchbauer-Müller

P577

2011-11-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221772567

http://www.w3.org/2001/XMLSchema#string

P698

22272089

http://www.w3.org/2001/XMLSchema#string

P932

3257086

http://www.w3.org/2001/XMLSchema#string

Biochip-based detection of KRAS mutation in non-small cell lung cancer.

about

P2860

P2860

Biochip-based detection of KRAS mutation in non-small cell lung cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932